Medizone still has in its possession a USPTO-granted patent on ozone-assisted wound healing: “ Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions,” USPTO # 6,073,627. It has 5 more years of life to go. Wound healing now commands a 20 billion annual market worldwide. Medizone could still become a genuine medical ozone company, in addition to a sterilization company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.